The report provides a detailed analysis essential for establishing a Triamterene production plant. It encompasses all critical aspects necessary for Triamterene production, including the cost of Triamterene production, Triamterene plant cost, Triamterene production costs, and the overall Triamterene production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Triamterene production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Triamterene is a potassium-sparing diuretic that is used to regulate hypertension and treat edema. By acting on the luminal side of the nephron, it increases the excretion of sodium ions and water while decreasing the excretion of potassium in the distal portion of the kidney. It is recommended for the treatment of edema brought on by cirrhosis of the liver, nephrotic syndrome, congestive heart failure, steroid-induced edema, idiopathic edema, and edema resulting from secondary hyperaldosteronism.
The procurement of Triamterene is influenced by its application in the pharmaceutical and medical industries to manage hypertension and edema. The need for Triamterene is increasing as cases of edema and hypertension are on the rise. It witnesses a significant demand from the aging population as they are more likely to be affected by hypertension. When combined with hydrochlorothiazide, Triamterene is recommended for the treatment of edema or the management of hypertension in patients who experience hypokalemia after starting hydrochlorothiazide monotherapy, thus increasing its demand. When taken with thiazides and loop diuretics, Triamterene helps to maintain the potassium balance. Triamterene can also be used to overcome diuretic resistance.
A diuretic synergism, which combines two different types of diuretics, such as Triamterene and a loop diuretic, can effectively overcome resistance and reduce edema. Blood pressure and fluid retention can be more effectively managed with this combined therapy approach, which increases its market potential. Overall, the industrial Triamterene procurement is influenced by its application in the pharmaceutical and medical industries, the rising cases of hypertension and edema, the aging population, its wide range of applications, its utilization with other drugs as combination therapy, fewer side effects, better tolerability, along with cost-effectiveness, research and development, and regulatory approvals.
Raw Material for Triamterene Production
According to the Triamterene production plant project report, the key raw materials used in the production of Triamterene include guanidine-malononitrile.
Production Process of Triamterene
The extensive Triamterene production cost report consists of the following major industrial production process:
- Production from guanidine and malononitrile: The production process of Triamterene starts with the reaction of guanidine and malononitrile to form 2,4,6-triaminopyrimidine in the presence of sodium methoxide. This intermediate is subjected to nitrosation in the presence of nitrous acid to obtain 5-nitroso-2,4,6-triaminopyrimidine. In the final step, 5-nitroso-2,4,6-triaminopyrimidine is condensed with benzyl cyanide using sodium methoxide that cyclizes to form Triamterene.
Triamterene is a yellow crystalline powder, having the molecular formula C12H11N7 and a molecular weight of 253.26 g/mol. It is initially almost tasteless and leaves a faintly unpleasant aftertaste. Solutions that have been acidified glow blue. It has a melting point of 316 °C. It is very weakly soluble in water, with a solubility of 0.963 mg/mL. It has a log P value of around 0.98. It remains stable in suggested storage conditions. The value of its dissociation constant, pKa, is 6.2. It is a potassium-sparing diuretic used to treat hypertension and edema.
